Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Neoplasm Metastasis 1Myofibroma 1Blood Loss, Surgical 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Misoprostol × 1 year × Clear all
NCT06850974 2026-04-30

Foley Balloon for Cervical Preparation Before Dilation and Evacuation

Stony Brook University

Phase NA Recruiting
102 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06669533 2025-10-01

MISOPCx

University of Alabama at Birmingham

Phase NA Recruiting
420 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT06882824 2025-09-24

HEMOMYOC

University Hospital, Clermont-Ferrand

Phase NA Recruiting
80 enrolled

Blood Loss, Surgical, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡